Related Experiment Video
Updated: May 12, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Majority of differentially expressed genes are down-regulated during malignant transformation in a four-stage model
Frida Danielsson1, Marie Skogs, Mikael Huss
1Science for Life Laboratory, Royal Institute of Technology (KTH), SE-17121 Solna, Sweden.
Abstract:
The transformation of normal cells to malignant, metastatic tumor cells is a multistep process caused by the sequential acquirement of genetic changes. To identify these changes, we compared the transcriptomes and levels and distribution of proteins in a four-stage cell model of isogenically matched normal, immortalized, transformed, and metastatic human cells, using deep transcriptome sequencing and immunofluorescence microscopy. The data show that ∼6% (n = 1,357) of the human protein-coding genes are differentially expressed across the stages in the model. Interestingly, the majority of these genes are down-regulated, linking malignant transformation to dedifferentiation. The up-regulated genes are mainly components that control cellular proliferation, whereas the down-regulated genes consist of proteins exposed on or secreted from the cell surface. As many of the identified gene products control basic cellular functions that are defective in cancers, the data provide candidates for follow-up studies to investigate their functional roles in tumor formation. When we further compared the expression levels of four of the identified proteins in clinical cancer cohorts, similar differences were observed between benign and cancer cells, as in the cell model. This shows that this comprehensive demonstration of the molecular changes underlying malignant transformation is a relevant model to study the process of tumor formation.
Insights
Malignant transformation involves genetic changes, often leading to dedifferentiation and altered cell surface proteins. This study identifies key gene expression changes relevant to tumor formation and cancer progression.
Area of Science:
- Molecular biology
- Cancer research
- Genomics
Background:
- Cancer development is a multistep process driven by accumulating genetic alterations.
- Understanding these molecular changes is crucial for identifying therapeutic targets.
Purpose of the Study:
- To identify and characterize gene and protein expression changes during malignant transformation.
- To validate a cell model for studying tumor formation and progression.
Main Methods:
- Deep transcriptome sequencing of a four-stage human cell model (normal, immortalized, transformed, metastatic).
- Immunofluorescence microscopy to analyze protein levels and distribution.
- Comparison of expression data with clinical cancer cohorts.
Main Results:
- Approximately 6% of human protein-coding genes showed differential expression across the cell model stages.
- The majority of differentially expressed genes were down-regulated, suggesting dedifferentiation.
- Upregulated genes primarily control cell proliferation, while downregulated genes include cell surface proteins.
Conclusions:
- The identified molecular changes in the cell model reflect key events in malignant transformation and tumor formation.
- Downregulation of cell surface proteins and basic cellular functions are linked to cancer progression.
- The study provides candidate genes and proteins for further investigation into their roles in cancer development.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

